Your browser doesn't support javascript.
loading
Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Dalai, Sudeb C; Dines, Jennifer N; Snyder, Thomas M; Gittelman, Rachel M; Eerkes, Tera; Vaney, Pashmi; Howard, Sally; Akers, Kipp; Skewis, Lynell; Monteforte, Anthony; Witte, Pamela R; Wolf, Cristina; Nesse, Hans; Herndon, Megan; Qadeer, Jia; Duffy, Sarah; Svejnoha, Emily; Taromino, Caroline; Kaplan, Ian M; Alsobrook, John; Manley, Thomas; Baldo, Lance.
  • Dalai SC; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Dines JN; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Snyder TM; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Gittelman RM; Adaptive Biotechnologies, Seattle, Washington, USA.
  • Eerkes T; Adaptive Biotechnologies, Seattle, Washington, USA.
  • Vaney P; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Howard S; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Akers K; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Skewis L; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Monteforte A; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Witte PR; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Wolf C; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Nesse H; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Herndon M; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Qadeer J; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Duffy S; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Svejnoha E; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Taromino C; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Kaplan IM; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Alsobrook J; T-Detect Product Management, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Manley T; Molecular Lab Management, Adaptive Biotechnologies, Seattle, Washington, USA.
  • Baldo L; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.
Clin Infect Dis ; 75(12): 2079-2087, 2022 12 19.
Article en En | MEDLINE | ID: mdl-35521791
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article